|
US2020080091A1
|
|
Methods for Treating Obesity of a Subject Suffering from Obesity
|
|
AU2017234903A1
|
|
Obesity risk diagnosis kit and method for analyzing risk of obesity onset
|
|
CN106163535A
|
|
Comprise the antiobesity agent of Semen Juglandis extract
|
|
JP2017112836A
|
|
Preparation methods of osteoporosis model animals
|
|
EP2954905A1
|
|
Screening method for pgc-1beta-protein-function regulator
|
|
WO2014103862A1
|
|
Obesity preventive or therapeutic agent and rheumatism preventive or therapeutic agent
|
|
WO2014103863A1
|
|
Screening method for compound having obesity preventive or therapeutic activity
|
|
CN103635588A
|
|
Method for screening substances having body-weight-regulating effect
|
|
US2009276863A1
|
|
Protein formulations comprising s1-5
|
|
EP1352961A1
|
|
Synovial cell protein
|
|
JPS62246393A
|
|
Folding screen
|
|
JPS6290303A
|
|
Production of trunk in artificial cherry or citrus tree
|
